MALIGNANT NEOPLASMS
Clinical trials for MALIGNANT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASMS trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink kidney tumors in Second-Line treatment
Disease control Recruiting nowThis study tests whether adding the experimental drug SLC-3010 to the standard drug axitinib works better than axitinib alone for people with advanced clear cell kidney cancer that has worsened after first treatment. About 78 adults will be randomly assigned to one of the two gro…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New pill combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new experimental drug (PF-07799544) combined with another drug (PF-07799933) in adults with advanced solid tumors that have a specific gene change called BRAF V600. The goal is to see if the combination is safe and can shrink or control the cancer. Participants…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
New pill for advanced tumors enters first human tests
Disease control Recruiting nowThis early-stage study tests a new daily pill, DEG6498, in about 100 adults with advanced solid tumors that have not responded to other treatments. The main goals are to find a safe dose and check for side effects. Researchers will also measure how the drug moves through the body…
Matched conditions: MALIGNANT NEOPLASMS
Phase: PHASE1 • Sponsor: Degron Therapeutics Co. • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
Scientists seek tissue samples to unlock cancer secrets
Knowledge-focused Recruiting nowThis study collects blood, urine, saliva, and tissue samples from people who have or may have cancer, as well as their blood relatives. The goal is to help researchers learn more about the genetic and molecular causes of cancer. No direct treatment is given, but the samples may l…
Matched conditions: MALIGNANT NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC